0000899140-24-001306.txt : 20241126 0000899140-24-001306.hdr.sgml : 20241126 20241126140114 ACCESSION NUMBER: 0000899140-24-001306 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20241126 DATE AS OF CHANGE: 20241126 EFFECTIVENESS DATE: 20241126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EP DFF L.P. CENTRAL INDEX KEY: 0001838403 ORGANIZATION NAME: IRS NUMBER: 854089707 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-385164 FILM NUMBER: 241501628 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 212-751-5959 MAIL ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 D/A 1 primary_doc.xml X0708 D/A LIVE 0001838403 EP DFF L.P. 375 PARK AVENUE NEW YORK NY NEW YORK 10152 212-751-5959 DELAWARE None None Limited Partnership true 2020 Joel S Ehrenkranz 375 Park Avenue, 28th Floor New York NY NEW YORK 10152 Executive Officer Investment Committee Member of the General Partner of the General Partner Sanford B Ehrenkranz 375 Park Avenue, 28th Floor New York NY NEW YORK 10152 Executive Officer Investment Committee Member of the General Partner of the General Partner John B Ehrenkranz 375 Park Avenue, 28th Floor New York NY NEW YORK 10152 Executive Officer Investment Committee Member of the General Partner of the General Partner Andrew Sommers 375 Park Avenue, 28th Floor New York NY NEW YORK 10152 Executive Officer Investment Committee Member of the General Partner of the General Partner Patrick JC Shaw 375 Park Avenue, 28th Floor New York NY NEW YORK 10152 Executive Officer Investment Committee Member of the General Partner of the General Partner Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.7 true 0000899140-23-001143 2021-01-01 true true true false 0 Indefinite 78313926 Indefinite false 20 0 0 0 false EP DFF L.P. Steven W Davidson Steven W Davidson Authorized Signatory 2024-11-26